Next generation MRD
- PMID: 25016196
- PMCID: PMC4209896
- DOI: 10.1016/j.bbmt.2014.07.002
Next generation MRD
Comment on
-
Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.Biol Blood Marrow Transplant. 2014 Sep;20(9):1307-13. doi: 10.1016/j.bbmt.2014.04.018. Epub 2014 Apr 24. Biol Blood Marrow Transplant. 2014. PMID: 24769317 Free PMC article.
References
-
- Logan AC, Vashi N, Faham M, Carlton V, Kong K, Buno I, et al. Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Apr 24; - PMC - PubMed
-
- Goldman JM, Gale RP. What does MRD in leukemia really mean? Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2014 May;28(5):1131. - PubMed
-
- Garand R, Beldjord K, Cave H, Fossat C, Arnoux I, Asnafi V, et al. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2013 Feb;27(2):370–376. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources